Dual Orexin Receptor Antagonist
Preclinical- Indications
- Insomnia
Company intelligence / Profile preview
bioSeedin
Cambridge, Massachusetts, United Statesbioseedin.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Phase 3
01
Overview
bioSeedin does not develop its own clinical-stage therapeutics but enables global licensing deals and co-development partnerships for assets spanning preclinical through late-stage development. Their annual BIOS conference has facilitated thousands of meetings leading to confirmed deals in oncology, rare diseases, next-gen modalities like bispecific antibodies and gene therapies.
- Therapeutic areas
- Rare DiseasesOncologyCardiovascularImmunology
- Modalities
- Antibodies (including bispecifics and ADCs)Small moleculesFusion proteinsRNAi therapeutics (via partnerships/events)Nanoparticle drug delivery platforms
- Industry
- Consulting
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Facilitates partnerships with top pharma companies globally including Pfizer, Novartis, Johnson & Johnson through parent group’s network.Partners with numerous biotech startups showcased at its events/conferences.
Beyond the preview
Go deeper on bioSeedin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bioSeedin.